Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of MOLAZ 200mg tablets:
MOLAZ 200mg Tablet is the first oral antiviral medication designed to treat mild to moderate COVID-19 in adults. Its mechanism of action involves inhibiting the replication of the virus, thereby reducing viral load and severity of the illness. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.
MOLAZ 200mg Tablet is specifically indicated for patients experiencing mild to moderate COVID-19 symptoms and who are at high risk of developing severe complications. Risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not recommended for patients requiring immediate hospitalization due to COVID-19. This medication has also been approved for emergency use by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency.
Uses of MOLAZ 200mg tablets:
Treatment of Mild to moderate Coronavirus disease (COVID-19)
Mechanism of action of MOLAZ 200mg tablets:
MOLAZ 200mg Tablet is an antiviral medication that works by inhibiting the SARS-CoV-2 virus from replicating. This action prevents the virus from producing new copies, thereby reducing the viral load in the body.